The power of the protein-processing machinery to operate as a modifier of disease outcomes has been shown recently by the demonstration that the activity of HSP90 (also known as HSP90AA1), the cytosolic paralog of GRP94, determined the severity of the cancer predisposition syndrome Fanconi anemia (Taipale et al., 2014). This evidence concerns the gene HSP90B1 and Fanconi anemia.